www.serelyspharma.com is the website of FCL Science B.V.(the "Website").
Your use of this Website is subject to compliance with the general terms and conditions of access and use (the "General Terms and Conditions of Use") set forth below and all applicable laws. By accessing the Website and browsing and using it, you unconditionally agree to the General Terms and Conditions of Use set forth below, which will prevail over any other agreement.
About FCL Science B.V.
FCL Science B.V. ("FCL Science or the "Company”)
A Dutch company with limited liability
Registered office: Herengracht 420- 1017BV Amsterdam (Netherlands)
Tel. 0031 202442388
Share capital: 100 €
Registration number at the Netherlands Chamber of Commerce: 73380423Represented by Mr Frédéric MORRA, Director
Publication Manager: Mr Sossio Morra
The host of the Website is nazwa.pl (https://www.nazwa.pl/)
Registered office: Mieczysław Medweckiego 17 - 31-870 Kraków, Poland
Purposes of the Website
FCL Science’s Website is the official website for the trademark Sérélys® in Europe.
FCL Science 's Website is for healthcare professionals (including but not limited to doctors and pharmacists) and the general public. The purpose of the Website is to publish information about Sérélys®’ products. Information appearing on the Website and liability.
The information provided on the Website is for information purposes only. It is not intended to replace any advice, treatment, diagnostics or recommendations by healthcare professionals (including but not limited to doctors and pharmacists), and may not be treated in any way as a medical opinion or as advice on the use of Sérélys®'s products. Accordingly, it cannot take the place of the relationship between a Website user and healthcare professionals (including but not limited to doctors and pharmacists).
The Website may publish various expert opinions and the content of articles published in the specialized press. The authors of such articles and expert opinions are solely responsible of their content. They are the expression of a personal point of view and will not engage the responsibility of FCL Science if they turn out to be inaccurate or incomplete.
FCL Science endeavors to update the information published on the Website.
FCL Science reserves the right to amend or remove the Website content at any time without prior notice and may not be held liable for the potential consequences of said changes. FCL Science further reserves the right to interrupt or suspend all or part of the Website's functions at any time without prior notice.
Notwithstanding the care taken by FCL Science with regard to the selection, truthfulness and oversight of the information contained in the Website and any updates to it, it is possible that the Website may contain errors, imprecisions or omissions. FCL Science cannot guarantee that the information contained in the Website is exhaustive or that it is accurate, whatever the information concerned may be.
FCL Science declines all liability for any direct or indirect damage, whether serious or not, that may derive from consulting the Website and/or any use a user may make of it. In addition, it is not liable for any harm resulting from fraudulent intrusion by a third party that may lead to the information in the Website being altered.
The content of this Website is protected by the texts and provisions governing copyright and literary and artistic property rights.
All texts, illustrations, logos and photographs in this Website are the property of Sérélys Pharma. All uses in the form of reproduction, modification, computer loading, alteration, transmission or partial or total distribution of a document or any information in the Website for anything other than strictly private purposes are prohibited in the absence of prior written consent from FCL Science.
The commercial names, brand names, trademarks and service marks, logos and products presented on the Website are protected in Monaco, France and worldwide. No use may be made of them without the prior written consent from FCL Science.
Protection of personal data
FCL Science undertakes to ensure that the collection and processing through the Website of the personal data of users of the Website, including any possible health related data, comply with Monaco Law no. 1165 of 23 December 1993 on personal data protection, as amended, the Data Protection Law no. 2018-493 of 20 June 2018 and Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of personal data. The information collected by the Website via its "Contact Form" is subject to computer processing that has the purpose of providing information on products to Website users and healthcare professionals.
Personal data collected as part of the use of the Website by Website users will not be retained by FCL Science for more than 2 years.
The data recipients are the Marketing and Sales Department, the Customer Service Department, the medical management team and the General Accounting Department.
Pursuant to Monaco Law no. 1.165 of 23 December 1993 on personal data protection, as amended and Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of personal data, interested parties have the right to oppose, modify, correct and delete information concerning them by writing to firstname.lastname@example.org.
To find out more, please consult your rights on the CCIN
Links to other websites
The www.serelyspharma.com Website may include hypertext links and references to other Internet websites, including Facebook, Twitter and Instagram. FCL Science does not exercise any control over the content of third-party Internet websites, and may not be held liable for any direct or indirect damage resulting from consultation of this content. All links to other Internet websites are created solely for ease of navigation for users of the Website. The creation of any hypertext link to the Website or any of its pages must be authorized in advance by FCL Science.
These General Terms and Conditions of Use of the Website are subject to Monegasque law. The Courts of Monaco will have sole jurisdiction in the event of a dispute, with the exception of disputes involving non-business customers, in which case the legal rules for the assignment of jurisdiction will apply.
This legal notice was updated on
4 november 2020